Find ABL at GTCbio’s Novel Immunotherapeutics Summit 2016
San Diego, CA – January 7, 2016 – Find ABL at GTCbio’s Novel Immunotherapeutics Summit 2016 in San Diego, CA Jan 25-26
ABL is attending Global Technology Community’s (GTCbio’s) Novel Immunotherapeutics Summit 2016 at the Paradise Point Resort & Spa. The summit has four colocated conferences, hosting scientists in the following key areas for which ABL immunoassay services may be needed:
- Cytokines & Inflammation
- Immunotherapeutics & Immunomonitoring
- Immunogenicity & Immunotoxicity
- Allergy, Asthma & COPD
ABL representatives will have a booth and hope to talk to academic and industry scientists about ABL’s immunological services. ABL seeks to help clients answer questions in immune pathway modulation, novel immunoassay development, immunotherapies, understanding phenotypes invovled in allergic diseases, and many other issues where ABL’s immunoligical expertise in immune responses could be beneficial.
About ABL, Inc.
ABL, Inc. is a global biomedical contract research and manufacturing organization dedicated to advancing vaccines, therapeutics and other biologic products. ABL has extensive experience working with diverse organizations, including the U.S. Government, biopharmaceutical companies and academic entities. Notable contract manufacturing services include process and assay development, cGMP biologics manufacturing of bulk drug substance, cGMP aseptic fill and finish of drug product, and QC analytics in the U.S. and Europe. ABL also maintains U.S. and European immunological and molecular laboratories to support preclinical and GCLP clinical sample processing and testing. ABL is a part of the Institut Mérieux, a group of companies dedicated to developing translational science for better patient care globally.
For more information visit www.ablinc.com or email us.
